27 No. 6
||News and information on IUPAC, its fellows, and members organizations
See also www.iupac.org/news
IUPAC-Richter Prize in Medicinal Chemistry
The IUPAC-Richter Prize in Medicinal Chemistry was established by a generous gift from the Chemical Works of Gedeon Richter, Ltd. (Budapest, Hungary) to acknowledge the key role that medicinal chemistry plays in improving human health. By establishing this prize jointly with IUPAC, Richter wishes to contribute to the international recognition of the role of research in medicinal chemistry, publicize the company’s commitment to medicinal chemistry research, and further appreciation of IUPAC’s activities.
The prize of USD 10 000 will be awarded to an internationally recognized scientist, preferably a medicinal chemist, whose activities or published accounts have made an outstanding contribution to the practice of medicinal chemistry or to an outstanding example of new drug discovery. The prize will be awarded biennially by a selection committee that will be appointed by the Subcommittee on Medicinal Chemistry and Drug Development of the IUPAC Chemistry and Human Health Division. The first prize will be awarded in 2006.
Gedeon Richter Ltd. is a major pharmaceutical company in Hungary and one of the largest in the Central-Eastern European region. Founded in 1901, the company has more than 100 years’ experience in pharmaceutical manufacturing. The vertically integrated firm carries out research, development, manufacture, and marketing of human finished drugs, active substances, and intermediates. Gedeon Richter Ltd. has a growing presence through its commercial subsidiaries in key EU countries, the USA, and Japan. Two-thirds of its annual sales of 599 million USD in 2004 were exported to 80 countries (Russia, USA, EU, Japan, etc.). Production takes place at two sites in Hungary: Budapest and Dorog. The company also has production facilities in Poland, Russia, Romania, Ukraine, and India. The company manufactures about 100 kinds of pharmaceuticals in more than 170 presentations. Among its products are original, generic, and licensed preparations. The products cover numerous therapeutic areas, with special emphasis on the production and development of drugs for the central nervous system, as well as antiulcer agents, cardiovascular and gastrointestinal preparations, and oral contraceptives. Research into drugs of the central nervous system and development of generic products are of primary importance. Based on its traditional skills in steroid chemistry, the company is a significant player in the gynaecological field worldwide.
last modified 28 October 2005.
Copyright © 2003-2005 International Union of Pure and
Questions regarding the website, please contact [email protected]